Registering its second biggest fall of the year, it concluded the session at 64.81
Total investment in the corporate debt category has reached Rs 2,42,094 crore
Firm plans to raise Rs 500 cr via QIPs
Bessemer to exit from the firm completely; exit amount fixed at Rs 144 cr
Nifty outlook and few trading ideas by Chandan Taparia, Derivative & Technical Analyst at Motilal Oswal Securities
Sebi has revoked the confirmatory orders against these 82 entities with immediate effect
Catch all that happened in the market here
The stock slipped below its issue price at Rs 950 after listing at pat against its IPO price of Rs 985 per share
Maker Laboratories, Gokaldas Exports, Tarmat, Palred Technologies, Viceroy Hotels and Bhagiradha Chemicals too locked in upper circuit of 20% on BSE.
The stock locked in upper circuit for the second straight day, up 20% at Rs 291, also its lifetime high on BSE.
The stock soared 19% to Rs 121, also its 52-week high on BSE on back of heavy volumes.
In past one month, the pharma index surged 13% as against 3% rise in the benchmark index
Since July 3, the bank announced the stock split plan the stock outperformed the market by surging 29% against 3.5% rise in Sensex
The stock moved higher by nearly 7% to Rs 2,466 on BSE in an otherwise weak market
Interview with chief global economist, Principal Global Investors
So far in 2017, the stock under-performed the market by falling 24% as compared to 22% rise in the S&P BSE Sensex till Wednesday.
Few trading ideas and Nifty outlook by Sacchitanand Uttekar, AVP - Technical (Equity)
The support for Nifty is seen at 10,100 while resistance is seen at 10,200.
Fund managers have increased their quantum of investments in the top 10 by 43% so far in 2017 to Rs 1.52 lakh crore, from Rs 1.06 lakh crore
Nifty, Bank Nifty, ITC, Ambuja Cements, BPCL